Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
For researchers building multi-compound metabolic panels, consider how retatrutide data integrates with findings from tirzepatide and semaglutide studies
This is significantly less expensive than pharmaceutical-grade products, which can cost $1,000 to $1,500 per month without insurance
Unforeseen Reactions In February 2025, the paper, Euglycemic Ketoacidosis Following Coadministration of an SGLT2 Inhibitor and Tirzepatide , appeared in JCEM Case Reports , describing a patient who was admitted to the intensive care unit after being placed on both medications
A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
US$ 29.42
US$ 28.24
)
US$ 25.51
